Description
Physicians need to carefully weigh the risks and benefits of treating psoriasis patients with biologics or immunosuppressant agents during the COVID-19 pandemic, says Jashin J. Wu, MD. Many factors affect this decision including the severity of the psoriasis as well as any underlying medical conditions that increase risk for a severe course of COVID-19 including diabetes, hypertension, or liver disease.
Presenters
